AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kazpride G 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Sakshit Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Kazpride G 1mg/500mg Tablet SR

Glyciphage-G 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate management strategies. Maintain regular meals and carry a readily available fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Avoid use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Kazpride G 1mg/500mg Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Kazpride G 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Kazpride G 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Kazpride G 1mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with food.

Common Side effects of Kazpride G 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Kazpride G 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Kazpride G 1mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with food.

How Kazpride G 1mg/500mg Tablet SR works:

Kazpride G 1mg/500mg Extended-Release Tablets combine glimepiride and metformin, two agents effective in managing diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Kazpride G 1mg/500mg SR tablet use is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Kazpride G 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Kazpride G tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Kazpride G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Kazpride G 1mg/500mg SR tablets. Consult a physician. Regular kidney function monitoring is recommended during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Kazpride G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, initiation at a low dose is typical; however, its use is contraindicated in severe liver disease.

What if you forget to take Kazpride G 1mg/500mg Tablet SR :

Should you forget a Kazpride G 1mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Kazpride G 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Kazpride G 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Kazpride G 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Kazpride G 1mg/500mg Tablet SR and seek immediate medical attention.
Kazpride G 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Kazpride G 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Kazpride G 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Kazpride G 1mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Kazpride G 1mg/500mg SR tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Kazpride G 1mg/500mg Tabl...
78
MRP 90
13% off